Serum properdin consumption as a biomarker of C5 convertase dysregulation in C3 glomerulopathy
24 p.-3 fig.-3 tab.
| Autores: | , , , , , , |
|---|---|
| Formato: | artículo |
| Estado: | Versión aceptada para publicación |
| Fecha de publicación: | 2016 |
| País: | España |
| Recursos: | Consejo Superior de Investigaciones Científicas (CSIC) |
| Repositorio: | DIGITAL.CSIC. Repositorio Institucional del CSIC |
| OAI Identifier: | oai:digital.csic.es:10261/138990 |
| Acesso em linha: | http://hdl.handle.net/10261/138990 |
| Access Level: | acceso abierto |
| Palavra-chave: | Alternative pathway C3 nephritic factor C3 glomerulopathy Complement C3 glomerulonephritis Properdin |
| id |
ES_aeb7b8d7e73a51e3c2fc9b76a0326b31 |
|---|---|
| oai_identifier_str |
oai:digital.csic.es:10261/138990 |
| network_acronym_str |
ES |
| network_name_str |
España |
| repository_id_str |
|
| spelling |
Serum properdin consumption as a biomarker of C5 convertase dysregulation in C3 glomerulopathyProperdin in C3 glomerulopathyCorvillo, FernandoBravo García-Morato, MaríaNozal, PilarGarrido, SofíaTortajada, AgustínRodríguez de Córdoba, SantiagoLópez-Trascasa, MargaritaAlternative pathwayC3 nephritic factorC3 glomerulopathyComplementC3 glomerulonephritisProperdin24 p.-3 fig.-3 tab.Properdin (P) stabilizes the alternative pathway (AP) convertases, being the only known positive regulator of complement system. In addition, P is a pattern recognition molecule able to initiate directly the AP on non-self surfaces. Although P deficiencies are long time known to be associated with Neisseria infections and P is often found deposited at sites of AP activation and tissue injury, the potential role of P in the pathogenesis of complement dysregulation associated disorders has not been extensively studied. Serum P levels were measured in 49 patients with histological and clinical evidence of C3 glomerulopathy (C3G). Patients were divided in two groups according to the presence or absence of C3 nephritic factor (C3NeF), an autoantibody that stabilizes the AP C3 convertase. The presence of this autoantibody results in a significant reduction in circulating C3 (p<0.001) and C5 levels (p<0.05), but does not alter factor B, P and sC5b-9 levels. Interestingly, in our cohort, serum P levels were low in 17 of the 32 C3NeF-negative patients. This group exhibited significant reduction of C3 (p<0.001) and C5 (p<0.001), and increase of sC5b-9 (p<0.001) plasma levels, compared to the control group. Besides, P consumption was significantly correlated with C3 (r= 0.798, p 0.0001), C5 (r= 0.806, p<0.0001), sC5b-9 (r = -0.683, p 0.043) and a higher degree of proteinuria (r= -0.862, p 0.013). These results further illustrate the heterogeneity among C3G patients and suggest that P serum levels could be a reliable clinical biomarker to identify patients with underlying surface AP C5 convertase dysregulation.This work was performed with the support of grants from the Spanish Ministerio de Economía y Competitividad (SAF2012-38636), Comunidad de Madrid (S2010/BMD-2316) and CIBERER (ACCI-2014).Peer reviewedJohn Wiley & SonsMinisterio de Economía y Competitividad (España)Comunidad de MadridConsejo Superior de Investigaciones Científicas [https://ror.org/02gfc7t72]201620162016info:eu-repo/semantics/articlehttp://purl.org/coar/resource_type/c_6501Postprintinfo:eu-repo/semantics/acceptedVersionhttp://hdl.handle.net/10261/138990reponame:DIGITAL.CSIC. Repositorio Institucional del CSICinstname:Consejo Superior de Investigaciones Científicas (CSIC)Ingléshttp://dx.doi.org/ 10.1111/cei.12754Síinfo:eu-repo/semantics/openAccessoai:digital.csic.es:10261/1389902026-05-22T06:33:51Z |
| dc.title.none.fl_str_mv |
Serum properdin consumption as a biomarker of C5 convertase dysregulation in C3 glomerulopathy Properdin in C3 glomerulopathy |
| title |
Serum properdin consumption as a biomarker of C5 convertase dysregulation in C3 glomerulopathy |
| spellingShingle |
Serum properdin consumption as a biomarker of C5 convertase dysregulation in C3 glomerulopathy Corvillo, Fernando Alternative pathway C3 nephritic factor C3 glomerulopathy Complement C3 glomerulonephritis Properdin |
| title_short |
Serum properdin consumption as a biomarker of C5 convertase dysregulation in C3 glomerulopathy |
| title_full |
Serum properdin consumption as a biomarker of C5 convertase dysregulation in C3 glomerulopathy |
| title_fullStr |
Serum properdin consumption as a biomarker of C5 convertase dysregulation in C3 glomerulopathy |
| title_full_unstemmed |
Serum properdin consumption as a biomarker of C5 convertase dysregulation in C3 glomerulopathy |
| title_sort |
Serum properdin consumption as a biomarker of C5 convertase dysregulation in C3 glomerulopathy |
| dc.creator.none.fl_str_mv |
Corvillo, Fernando Bravo García-Morato, María Nozal, Pilar Garrido, Sofía Tortajada, Agustín Rodríguez de Córdoba, Santiago López-Trascasa, Margarita |
| author |
Corvillo, Fernando |
| author_facet |
Corvillo, Fernando Bravo García-Morato, María Nozal, Pilar Garrido, Sofía Tortajada, Agustín Rodríguez de Córdoba, Santiago López-Trascasa, Margarita |
| author_role |
author |
| author2 |
Bravo García-Morato, María Nozal, Pilar Garrido, Sofía Tortajada, Agustín Rodríguez de Córdoba, Santiago López-Trascasa, Margarita |
| author2_role |
author author author author author author |
| dc.contributor.none.fl_str_mv |
Ministerio de Economía y Competitividad (España) Comunidad de Madrid Consejo Superior de Investigaciones Científicas [https://ror.org/02gfc7t72] |
| dc.subject.none.fl_str_mv |
Alternative pathway C3 nephritic factor C3 glomerulopathy Complement C3 glomerulonephritis Properdin |
| topic |
Alternative pathway C3 nephritic factor C3 glomerulopathy Complement C3 glomerulonephritis Properdin |
| description |
24 p.-3 fig.-3 tab. |
| publishDate |
2016 |
| dc.date.none.fl_str_mv |
2016 2016 2016 |
| dc.type.none.fl_str_mv |
info:eu-repo/semantics/article http://purl.org/coar/resource_type/c_6501 Postprint info:eu-repo/semantics/acceptedVersion |
| format |
article |
| status_str |
acceptedVersion |
| dc.identifier.none.fl_str_mv |
http://hdl.handle.net/10261/138990 |
| url |
http://hdl.handle.net/10261/138990 |
| dc.language.none.fl_str_mv |
Inglés |
| language_invalid_str_mv |
Inglés |
| dc.relation.none.fl_str_mv |
http://dx.doi.org/ 10.1111/cei.12754 Sí |
| dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess |
| eu_rights_str_mv |
openAccess |
| dc.publisher.none.fl_str_mv |
John Wiley & Sons |
| publisher.none.fl_str_mv |
John Wiley & Sons |
| dc.source.none.fl_str_mv |
reponame:DIGITAL.CSIC. Repositorio Institucional del CSIC instname:Consejo Superior de Investigaciones Científicas (CSIC) |
| instname_str |
Consejo Superior de Investigaciones Científicas (CSIC) |
| reponame_str |
DIGITAL.CSIC. Repositorio Institucional del CSIC |
| collection |
DIGITAL.CSIC. Repositorio Institucional del CSIC |
| repository.name.fl_str_mv |
|
| repository.mail.fl_str_mv |
|
| _version_ |
1869416604845998080 |
| score |
15.198674 |